413 related articles for article (PubMed ID: 7678980)
21. Ectopic expression of c-kit in small-cell lung cancer.
Hida T; Ueda R; Sekido Y; Hibi K; Matsuda R; Ariyoshi Y; Sugiura T; Takahashi T; Takahashi T
Int J Cancer Suppl; 1994; 8():108-9. PubMed ID: 7515024
[TBL] [Abstract][Full Text] [Related]
22. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.
Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH
Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809
[TBL] [Abstract][Full Text] [Related]
23. Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met.
Weidner KM; Hartmann G; Sachs M; Birchmeier W
Am J Respir Cell Mol Biol; 1993 Mar; 8(3):229-37. PubMed ID: 8383506
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor as a hematopoietic regulator.
Nishino T; Hisha H; Nishino N; Adachi M; Ikehara S
Blood; 1995 Jun; 85(11):3093-100. PubMed ID: 7538816
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer.
Nagy J; Curry GW; Hillan KJ; McKay IC; Mallon E; Purushotham AD; George WD
Surg Oncol; 1996 Feb; 5(1):15-21. PubMed ID: 8837300
[TBL] [Abstract][Full Text] [Related]
26. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue.
Strohmeyer T; Reese D; Press M; Ackermann R; Hartmann M; Slamon D
J Urol; 1995 Feb; 153(2):511-5. PubMed ID: 7529338
[TBL] [Abstract][Full Text] [Related]
27. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat.
Fujio K; Evarts RP; Hu Z; Marsden ER; Thorgeirsson SS
Lab Invest; 1994 Apr; 70(4):511-6. PubMed ID: 7513770
[TBL] [Abstract][Full Text] [Related]
28. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
[TBL] [Abstract][Full Text] [Related]
29. [Coexpression of hepatocyte growth factor-scatter factor (HGF-SF) and HGF-SF receptors (c-met proto-oncogene) in mammalian brain].
Schirmacher P; Jung W; Castren E; Lindholm D; Odenthal M; Dienes HP
Verh Dtsch Ges Pathol; 1994; 78():432. PubMed ID: 7534016
[No Abstract] [Full Text] [Related]
30. Hepatocyte growth factor-scatter factor (HGF-SF) and the c-met receptor. Introduction.
Goldberg ID; Rosen EM
EXS; 1993; 65():xiii-xv. PubMed ID: 8380733
[No Abstract] [Full Text] [Related]
31. Radiosensitivity of small-cell lung cancer xenografts compared with activity of c-myc, N-myc, L-myc, c-raf-1 and K-ras proto-oncogenes.
Rygaard K; Slebos RJ; Spang-Thomsen M
Int J Cancer; 1991 Sep; 49(2):279-84. PubMed ID: 1652570
[TBL] [Abstract][Full Text] [Related]
32. [A new strategy for treating small cell lung cancer].
Ueda R; Takashi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():111-4. PubMed ID: 9216197
[TBL] [Abstract][Full Text] [Related]
33. Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells.
Tomeczkowski J; Beilken A; Frick D; Wieland B; König A; Falk MH; Reiter A; Welte K; Sykora KW
Blood; 1995 Aug; 86(4):1469-80. PubMed ID: 7543307
[TBL] [Abstract][Full Text] [Related]
34. Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas.
Kunkel P; Müller S; Schirmacher P; Stavrou D; Fillbrandt R; Westphal M; Lamszus K
Neuro Oncol; 2001 Apr; 3(2):82-8. PubMed ID: 11296484
[TBL] [Abstract][Full Text] [Related]
35. Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor.
Zhang YW; Su Y; Lanning N; Gustafson M; Shinomiya N; Zhao P; Cao B; Tsarfaty G; Wang LM; Hay R; Vande Woude GF
Oncogene; 2005 Jan; 24(1):101-6. PubMed ID: 15531925
[TBL] [Abstract][Full Text] [Related]
36. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
37. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
38. Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF).
Aye MT; Hashemi S; Leclair B; Zeibdawi A; Trudel E; Halpenny M; Fuller V; Cheng G
Exp Hematol; 1992 May; 20(4):523-7. PubMed ID: 1373691
[TBL] [Abstract][Full Text] [Related]
39. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
Wang ZX; Lu BB; Yang JS; Wang KM; De W
J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
